Stock Events

Stock Events

Chromocure 

$0.000001
4
+$0.00+0%Thursday 14:30

Statistics

Day High
0.000001
Day Low
0.000001
52W High
0.0001
52W Low
0.000001
Volume
1,500,065
Avg. Volume
20,757,086
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap23.99B
Guardant Health focuses on cancer diagnostics through liquid biopsies, competing in the cancer detection market.
Fulgent Genetics
FLGT
Mkt Cap567.37M
Fulgent Genetics offers comprehensive genetic testing, including for cancer, making it a competitor in genetic diagnostics.
Pacific Biosciences of California
PACB
Mkt Cap809.71M
Pacific Biosciences provides sequencing systems that can be used for cancer research and diagnostics, competing in the genomics space.
Illumina
ILMN
Mkt Cap35.63B
Illumina offers sequencing and array-based solutions for genetic analysis, which are crucial in cancer research and diagnostics.
Bionano Genomics
BNGO
Mkt Cap16.07M
Bionano Genomics focuses on genomic analysis, including cancer research, competing in the genomics and diagnostics field.
TG Therapeutics
TGTX
Mkt Cap9.36B
TG Therapeutics focuses on developing treatments for cancer, making it a competitor in the broader cancer treatment and diagnostics market.
CRISPR Therapeutics
CRSP
Mkt Cap4.97B
CRISPR Therapeutics is involved in gene editing, which has applications in cancer treatment and diagnostics, competing in the innovative treatment solutions market.
Intellia Therapeutics
NTLA
Mkt Cap1.75B
Intellia Therapeutics is a leader in CRISPR/Cas9 technology for gene editing, including potential cancer therapies, competing in the genetic editing space for cancer solutions.

About

ChromoCure, Inc. specializes in designing and delivering exclusive systems for cancer identification. Their primary offering, the Chromosomal Scanner Series 200, is a detection system capable of identifying a distinct genomic characteristic that is universally present in all cancers yet entirely absent in healthy cells. Furthermore, the company dedicates its scientific and technological expertise to investigating non-toxic and non-invasive strategies for both cancer treatment and cure research. Established in 2001 and based in Reno, Nevada, the organization rebranded as ChromoCure, Inc. in June 2009, having previously been known as Cyberhand Technologies International, Inc.
Show More
CEO
Employees
4
Country
United States
ISIN
US1711271031

Listings

OTC Link
US
KKUR

0 Comments

Share your thoughts

FAQs

What is Chromocure stock price today?▼
The current price of KKUR is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Chromocure stock price performance more closely on the chart.
What is Chromocure stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Chromocure stocks are traded under the ticker KKUR.
How many employees does Chromocure have?▼
As of November 2, 2026, the company has 4 employees.
In which sector is Chromocure located?▼
Chromocure operates in the Health & Wellness sector.
When did Chromocure complete a stock split?▼
Chromocure has not had any recent stock splits.
Where is Chromocure headquartered?▼
Chromocure is headquartered in Reno, United States.